New cocktail of drugs and radiation takes on tough lung cancer
Disease control
Completed
This phase 2 trial tested whether adding two newer drugs—GFH018 and toripalimab—to standard chemoradiotherapy could help people with stage III non-small cell lung cancer that cannot be surgically removed. The study enrolled 65 adults and measured how many patients saw their tumor…
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC